Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.18% | 131.65 | 0.7% | $952.19m | |
| PFE | Pfizer Inc. | 0.49% | 36.69 | 0.9% | $757.40m | |
| MRK | Merck & Co., Inc. | 1.43% | 85.17 | 0.7% | $678.51m | |
| ABBV | AbbVie, Inc. | 0.99% | 72.38 | 2.3% | $543.60m | |
| BMY | Bristol-Myers Squibb Company | 0.98% | 50.56 | 1.4% | $467.46m | |
| LLY | Eli Lilly and Company | 1.59% | 116.17 | 1.0% | $379.52m | |
| AZN | AstraZeneca PLC Sponsored ADR | 1.28% | 45.18 | 1.2% | $146.91m | |
| NVS | Novartis AG Sponsored ADR | 0.79% | 87.03 | 0.2% | $130.76m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.75% | 41.63 | 0.3% | $85.05m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 2.02% | 52.93 | 0.1% | $78.51m | |
| SNY | Sanofi Sponsored ADR | 3.43% | 46.46 | 0.2% | $61.74m | |
| LCI | Lannett Company, Inc. | 2.83% | 13.79 | 35.6% | $53.98m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 0.52% | 1.94 | 1.6% | $2.11m | |
| EPIX | ESSA Pharma Inc | -6.23% | 2.86 | 0.1% | $0.19m |
Company Profile
Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.